Capturing Chemotherapy and Radiotherapy Dose Among Breast Cancer Patients With the Utah All‐Payer Claims Database Compared With Gold‐Standard Abstraction is a dataset published in Cancer Medicine (2024). On theSindex it has a DataRank of 0, placing it in the top 100% of the data-sharing corpus. Its calibrated FAIR score is 15/100.
Ranks in the top 100% for downstream scientific impact
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
Full FAIR picture · advisory
The headline score is computed from the scored criteria — the fact-shaped checks (a repository, an accession, a licence) that two independent models agree on. The advisory criteria below are real FAIR guidance but rest on judgment calls that models read differently, so they inform without moving the number.
No persistent identifier string (DOI, Handle, ARK, or repository accession) is assigned to the dataset in the paper.
RDA-F1-01D — FAIR Data Maturity Model: 'Data is identified by a persistent identifier' (priorit · RDA-F1-02D — FAIR Data Maturity Model: 'Data is identified by a globally unique identifier' · FsF-F1-02D — F-UJI/FAIRsFAIR: 'Data is assigned a persistent identifier'
“Data used for this study can be accessed through the approval of the Resource for Genetic and Epidemiologic Research Committee (RGE), the oversight committee for the UPDB and IRB.”
The holder named is an institutional committee (RGE), not a data repository listed in re3data/FAIRsharing. [majority verdict 'no' (4/5 passes agreed)]
RDA-F4-01M — FAIR Data Maturity Model: metadata is offered so it can be harvested and indexed ( · NIH DMS Policy Element 4 (NOT-OD-21-014) — name the repository where data will be archived · NSTC Desirable Characteristics of Data Repositories (2022) — 'Long-Term Sustainability', 'Reten
No identifier for the dataset appears anywhere in the paper, either in the reference list or in the body text.
FORCE11 Joint Declaration of Data Citation Principles (2014) — data should be cited as a first- · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes · FsF-F3-01M — F-UJI: 'Metadata includes the identifier of the data it describes'
Advisory · not in the published score
“Data used for this study can be accessed through the approval of the Resource for Genetic and Epidemiologic Research Committee (RGE), the oversight committee for the UPDB and IRB.”
The data-availability statement exists but points to a third-party controlled-access route, not to a repository record (Colavizza category 3) nor to the article or a request to authors.
Colavizza, Hrynaszkiewicz, Staden, Whitaker & McGillivray (2020), 'The citation advantage of li · Springer Nature research data policy — Data Availability Statements: standard statement templat · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes
“cancer treatments were abstracted for 197 breast cancer patients ages ≤ 65 at breast cancer diagnosis in 2013.”
The dataset's content and extent are described in running prose (number of patients and inclusion criteria), but no itemised inventory (section, table, or list of files) is provided. [majority verdict 'partial' (4/5 passes agreed)]
RDA-F2-01M — 'Rich metadata is provided to allow discovery' (priority Essential) · FsF-F2-01M — F-UJI: 'Metadata includes descriptive core elements to support data findability' · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data'
“Data used for this study can be accessed through the approval of the Resource for Genetic and Epidemiologic Research Committee (RGE), the oversight committee for the UPDB and IRB.”
The data availability statement specifies a followable process with a precondition (committee approval), not unconditional open access.
RDA-A1.1-01D — 'Data is accessible through a free access protocol' · FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · NSTC Desirable Characteristics of Data Repositories (2022) — 'Free and Easy Access'
Advisory · not in the published score
“Data used for this study can be accessed through the approval of the Resource for Genetic and Epidemiologic Research Committee (RGE), the oversight committee for the UPDB and IRB.”
The data availability statement describes an action (approval by RGE committee) from which the access level must be inferred, but no explicit access-level label is applied. [majority verdict 'partial' (3/5 passes agreed)]
FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · RDA-A1-01M — metadata contains information to enable the user to get access to the data · COAR Controlled Vocabularies — Access Rights v1.0 (open / embargoed / restricted / metadata-onl
“Data used for this study can be accessed through the approval of the Resource for Genetic and Epidemiologic Research Committee (RGE), the oversight committee for the UPDB and IRB.”
The data are human-subject data, and an institutional gatekeeper (the Resource for Genetic and Epidemiologic Research Committee) is named as the approval body.
NIH Genomic Data Sharing Policy (NOT-OD-14-124) — controlled-access via a Data Access Committee · RDA-A1.2-01D — 'Data is accessible through an access protocol that supports authentication and · NIH DMS Policy Element 5 (NOT-OD-21-014) — Access, Distribution, or Reuse Considerations (conse
The paper neither states how long the data will persist nor when they become available; no temporal commitment is made.
NIH DMS Plan Element 4 (NOT-OD-21-014) — Data Preservation, Access, and Associated Timelines · NSTC Desirable Characteristics (2022), Organizational Infrastructure: 'Retention Policy' · RDA-A2-01M — 'Metadata is guaranteed to remain available after data is no longer available'
No file format for the released data is named anywhere in the paper.
FsF-R1.3-02D — F-UJI: 'Data is available in a file format recommended by the target research co · RDA-R1.3-02D — data is expressed in a machine-understandable community standard · RDA-I1-01D — data uses a knowledge representation expressed in a standardised format
Advisory · not in the published score
No data or metadata community standard (e.g., MIAME, ISA-Tab, an ontology) is named as applying to the dataset; the tools used (HCPCS, NCCN) are not data-description standards. [majority verdict 'no' (4/5 passes agreed)]
RDA-R1.3-01M — 'Metadata complies with a community standard' (priority Essential) · RDA-R1.3-01D — 'Data complies with a community standard' · RDA-I2-01M — '(Meta)data use vocabularies that follow FAIR principles'
No identifier (accession, DOI, RRID, etc.) is given for any external resource used by the study (e.g., APCD, UCR, reference databases).
RDA-I3-01M — '(meta)data include references to other (meta)data' · RDA-I3-03M — 'metadata includes qualified references to other metadata' · FsF-I3-01M — F-UJI: 'Metadata includes links between the data and its related entities'
No licence or terms-of-use document is named for the dataset; the CC BY licence applies only to the article.
RDA-R1.1-01M — 'Metadata includes information about the licence under which the data can be reu · RDA-R1.1-02M — 'Metadata refers to a standard reuse licence' · RDA-R1.1-03M — 'Metadata refers to a machine-understandable reuse licence'
“for patients diagnosed in 2013 with breast cancer.”
The paper provides a data cut-off date (diagnosis year 2013), which pins the snapshot, but no version token is given. [majority verdict 'partial' (3/5 passes agreed)]
DataCite Metadata Schema 4.6 — the 'Version' property · RDA-R1.2-01M — provenance information (which version was used is provenance) · NSTC Desirable Characteristics of Data Repositories (2022) — 'Provenance', 'Retention Policy'
No code or software availability is mentioned; only third-party tools are named.
NIH DMS Policy Element 2 (NOT-OD-21-014) — 'Related Tools, Software and/or Code' · FAIR4RS Principles v1.0 (Chue Hong et al., 2022; RDA/FORCE11/ReSA) — FAIR Principles for Resear · FORCE11 Software Citation Principles (Smith, Katz & Niemeyer, 2016, PeerJ CS 2:e86)
“This work was supported by Huntsman Cancer Foundation, Huntsman Cancer Institute, University of Utah, the US Centers for Disease Control and Prevention's National Program of Cancer Registries, NU58DP0063200‐01, University of Utah, HCI Cancer Center Support Grant, P30 CA42014, National Cancer Institute, RRSS HHSN261201300017I/HHSN26100008, and National Institutes of Health (T32CA190194).”
The funding section includes specific award numbers (e.g., NU58DP0063200-01, P30 CA42014, T32CA190194) attached to named funders.
DataCite Metadata Schema 4.6 — 'FundingReference' property (funderName, funderIdentifier, award · Crossref Funder Registry — canonical funder identifiers for funding metadata · RDA-F2-01M — rich metadata provided to allow discovery (funding is part of the descriptive reco
Advisory · not in the published score
The data production process is described in generic terms without naming specific instruments, kits, or software versions. [majority verdict 'no' (3/5 passes agreed)]
RDA-R1.2-01M — 'Metadata includes provenance information according to community- specific standa · FsF-R1.2-01M — F-UJI: 'Metadata includes provenance information about data creation or generati · W3C PROV-O (W3C Recommendation, 2013) — the entity/activity/agent model of provenance
No documentation object (README, data dictionary) is said to accompany the data, and no variable-definition table is provided inside the article. [majority verdict 'no' (3/5 passes agreed)]
RDA-R1-01M — '(Meta)data are richly described with a plurality of accurate and relevant attribu · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data' · NIH DMS Policy Element 3 (NOT-OD-21-014) — Standards (documentation and metadata to accompany t
Calibrated FAIR score — a parallel quality metric, independent of the DataRank citation score. See the full evaluation →
National Cancer Institute
Grant: RRSS HHSN261201300017I/HHSN26100008
HCI Cancer Center Support Grant
Grant: P30 CA42014
the US Centers for Disease Control and Prevention's National Program of Cancer Registries
Grant: NU58DP0063200-01
NCI NIH HHS
Grant: T32 CA190194
NCI NIH HHS
Grant: P30 CA042014
Huntsman Cancer Foundation
Huntsman Cancer Institute, University of Utah
National Institutes of Health
University of Utah
NCI of the National Institutes of Health (T32CA190194)
NIH HHS
FWCI
0.00
Citation Percentile
0.2%
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals